Results of Intravascular Stent Placement for Fibrosing Mediastinitis

Congenital Heart Disease

Volumn 5, Issue 2, 2010, Pages 124-133

  Ferguson, Matthew E ^a   Cabalka, Allison K ^a   Cetta, Frank ^a   Hagler, Donald J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Fibrosing; Histoplasma; Intravascular; Mediastinitis; Sclerosing; Stent

Indexed keywords

CLOPIDOGREL; ITRACONAZOLE; RAPAMYCIN;

ADULT; ANTICOAGULANT THERAPY; ARTERIOGRAPHY; ARTICLE; BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; ECHOCARDIOGRAPHY; FATALITY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEMODYNAMICS; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; IN-STENT RESTENOSIS; MALE; MEDIASTINITIS; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; PULMONARY VEIN OBSTRUCTION; SEROLOGY; STENT; SUPERIOR CAVA VEIN OBSTRUCTION; VASCULAR PATENCY;

ADULT; ANGIOPLASTY, BALLOON; CONSTRICTION, PATHOLOGIC; FEMALE; FIBROSIS; HUMANS; HYPERTENSION, PULMONARY; MALE; MEDIASTINITIS; MIDDLE AGED; PULMONARY ARTERY; PULMONARY VEINS; RECURRENCE; STENTS; SUPERIOR VENA CAVA SYNDROME; VASCULAR DISEASES; VASCULAR PATENCY; VENA CAVA, SUPERIOR; YOUNG ADULT;

EID: 77954375970     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00387.x     Document Type: Article

References (30)

1. Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine. 1972, 51:227-246.
2. Levison ME. Pneumonia, including necrotizing pulmonary infections (lung abscess). Harrison's Principles of Internal Medicine 1998, 1437-1445. Fauci ASBraunwald EIsselbacher KJ. eds., 14th, edn., San Francisco, CA, McGraw-Hill
3. Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore). 1988, 67:295-310.
4. Mitchell IM, Saunders NR, Maher O, Lennox SC, Walker DR. Surgical treatment of idiopathic mediastinal fibrosis: report of five cases. Thorax. 1986, 41:210-214.
5. Sherrick AD, Brown LR, Harms GF, Myers JL. The radiographic findings of fibrosing mediastinitis. Chest. 1994, 106:484-489.
6. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006, 85:37-42.
7. Garrett HE, Roper CL. Surgical intervention in histoplasmosis. Ann Thorac Surg. 1986, 42:711-722.
8. Mathisen DJ, Grillo HC. Clinical manifestation of mediastinal fibrosis and histoplasmosis. Ann Thorac Surg. 1992, 54:1053-1057. Discussion 57-58
9. Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med. 2001, 164:657-660.
10. Eguchi KKK, Hasegawa I, Nakatsuka S. Restenosis of superior vena cava after treatment using a self-expanding metallic stent in a patient with idiopathic fibrosing mediastinitis. Interactive Cardiovasc Thorac Surg. 2003, 2:3.
11. Kandzari DE, Warner JJ, O'Laughlin MP, Harrison JK. Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis. Catheter Cardiovasc Interv. 2000, 49:321-324.
12. Smith SJ, Vyborny CJ, Hines JL. Re: chronic superior vena cava occlusion related to fibrosing mediastinitis treated with self-expanding shunts. Cardiovasc Intervent Radiol. 1997, 20:161-162.
13. Dodds GA, Harrison JK, O'Laughlin MP, Wilson JS, Kisslo KB, Bashore TM. Relief of superior vena cava syndrome due to fibrosing mediastinitis using the Palmaz stent. Chest. 1994, 106:315-318.
14. Lanciego C, Chacon JL, Julian A. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2001, 177:585-593.
15. Veroux P, Veroux M, Bonanno MG, Tumminelli MG, Baggio E, Petrillo G. Long-term success of endovascular treatment of benign superior vena cava occlusion with chylothorax and chylopericardium. Eur Radiol. 2002, 12(3):S181-S184. Suppl
16. Guerrero A, Hoffer EK, Hudson L, Schuler P, Karmy-Jones R. Treatment of pulmonary artery compression due to fibrous mediastinitis with endovascular stent placement. Chest. 2001, 119:966-968. see comment
17. Fierro-Renoy C, Velasquez H, Zambrano JP, Ridha M, Kessler K, Schob A. Percutaneous stenting of bilateral pulmonary artery stenosis caused by malignant extrinsic compression. Chest. 2002, 122:1478-1480.
18. Satpathy R, Aguila V, Mohiuddin SM, Khan IA. Fibrosing mediastinitis presenting as pulmonary stenosis: stenting works. Int J Cardiol. 2007, 118:e85-e86.
19. Taylor AJ, Gorman PD, Kenwood B, Hudak C, Tashko G, Virmani R. A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model. Catheter Cardiovasc Interv. 2001, 53:420-425.
20. Konig A, Schiele TM, Rieber J, Theisen K, Mudra H, Klauss V. Stent design-related coronary artery remodeling and patterns of neointima formation following self-expanding and balloon-expandable stent implantation. Catheter Cardiovasc Interv. 2002, 56:478-486.
21. Prieto LR, Schoenhagen P, Arruda MJ, Natale A, Worley SE. Comparison of stent versus balloon angioplasty for pulmonary vein stenosis complicating pulmonary vein isolation. J Cardiovasc Electrophysiol. 2008, 19:673-678.
22. Cook AL, Prieto LR, Delaney JW, Rhodes JF. Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis. Am J cardiol. 2006, 98:407-410.
23. Holmes DR, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv. 2009, 2:267-276.
24. Turco MA, Buchbinder M, Popma JJ. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Catheter Cardiovasc Interv. 2006, 68:379-388.
25. Giles H, Lesar C, Erdoes L, Sprouse R, Myers S. Balloon-expandable covered stent therapy of complex endovascular pathology. Ann Vasc Surg. 2008, 22:762-768.
26. Hausleiter J, Kastrati A, Mehilli J. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation. 2004, 110:790-795.
27. Rodriguez AE, Granada JF, Rodriguez-Alemparte M. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) study. J Am Coll Cardiol. 2006, 47:1522-1529.
28. Waksman R, Ajani AE, Pichard AD. Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study. J Am Coll Cardiol. 2004, 44:1386-1392.
29. Bromberg-Marin G, Tsimikas S, Mahmud E. Treatment of recurrent pulmonary vein stenoses with endovascular stenting and adjuvant oral sirolimus. Catheter Cardiovasc Interv. 2007, 69:362-368.
30. Kaludercic N, Lindsey ML, Tavazzi B, Lazzarino G, Paolocci N. Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond. Cardiovasc Ther. 2008, 26:24-37.